# Keynote Case Study: World Pharma Innovation Congress: Hyper-Science Is Rewriting The Future Of Pharma.
By 

## Article Content
I opened the World Pharma Innovation Congress in London with a message about rapid scientific acceleration, global collaboration and the innovation opportunity emerging across the life sciences. The keynote, “The Future of Pharma,” argued that hyper-science was rewriting the future of the industry. Hyper-science, open innovation, global collaboration, faster knowledge cycles and growth opportunity were converging into a single story about speed. Six trends are shaping that shift. Accelerating Medical Science. The knowledge base is expanding at extraordinary speed. Genomics & Personalization. Therapies are becoming more targeted and individualized. Open Innovation. Outside ideas and external partnerships are driving progress. Connected Healthcare. Digital and device connectivity are changing care delivery and data. Global Idea Networks. Collaboration across borders is speeding discovery. Changing Patient Expectations. Empowerment, information and outcomes matter more than ever. The future of pharma belongs to those who move at the speed of science. Pharma is one of several industries where I keep making the same argument on stage. The organizations that win are the ones willing to move as fast as the science underneath them. You can browse more of that work in the case studies collection here.

---
Source: https://jimcarroll.com/2026/09/world-pharma-innovation-congress-hyper-science-is-rewriting-the-future-of-pharma/